Form 4: Calix Director Carl Russo Receives Stock Option Grant Under 10b5-1 Plan
Insider Transaction Report
Calix Director and 10% Owner Carl Russo was granted 11,561 stock options with an exercise price of $53.19, vesting annually over four years, as part of a pre-arranged Rule 10b5-1 plan.
Summary
- Carl Russo, a Director and 10% Owner of Calix, Inc. (CALX), was granted 11,561 stock options.
- Each option represents the right to buy one share of Calix common stock.
- The exercise price for these options is $53.19 per share.
- The options were granted on June 30, 2025.
- The options vest and become exercisable with respect to 25% of the shares on each anniversary of the grant date (June 30, 2025).
- The options have an expiration date of June 30, 2035.
- This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction.
Sentiment
Score: 7
Explanation: The grant of stock options to a director and significant owner is generally viewed positively as it aligns their interests with long-term shareholder value. The transaction being under a 10b5-1 plan indicates a pre-planned, non-discretionary event, which is a neutral to positive governance practice.
Positives
- The grant of stock options to a director and significant owner aligns their interests with the long-term performance and shareholder value of Calix, Inc.
- The transaction was executed pursuant to a Rule 10b5-1(c) plan, which indicates a pre-scheduled, non-discretionary transaction designed to comply with insider trading rules.
Future Outlook
The granted stock options will vest annually over the next four years, starting from June 30, 2025, allowing for future exercise and potential acquisition of common stock.
Industry Context
This filing is a routine disclosure of an insider equity transaction, common across publicly traded companies as part of executive and director compensation structures. It does not provide broader industry trends or competitive insights.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Trading Plan | The transaction was made pursuant to a Rule 10b5-1(c) plan, which is a pre-arranged trading plan designed to avoid insider trading allegations. | 06/30/2025 | Enhances transparency and demonstrates adherence to best practices for insider trading compliance. |
Stakeholder Impact
- Shareholders: The grant of options to a director and 10% owner aligns their financial incentives with the company's stock performance, potentially benefiting shareholders through shared long-term value creation.
Next Steps
- The stock options will vest annually at 25% increments on each anniversary of the June 30, 2025 grant date.
- Carl Russo may choose to exercise the vested options at any time before their expiration on June 30, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of earliest transaction and option grant date. |
| 06/30/2026 | First vesting date, when 25% of the options become exercisable. |
| 07/16/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
| 06/30/2035 | Expiration date of the stock options. |
Keywords
Calix, CALX, Stock Options, Insider Transaction, SEC Form 4, Corporate Governance, Director Compensation, Equity Grant, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.